EUVIMEDOpdag EUVIMED
Crossref

Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes

Neslihan Gürcan Kaya iD, Hakan Öztürk iD, Sinan Sarı iD, Ödül Eğritaş Gürkan iD, Buket Dalgıç iD

Journal of Paediatrics and Child Health · 2025

DOI: 10.1111/jpc.70072 ↗

At a glance

Journal article in Journal of Paediatrics and Child Health, 2025. Written by Neslihan Gürcan Kaya and 4 co-authors. Institution: Department of Pediatric Gastroenterology, Ankara Training and Research Hospital, Ankara, Turkey. Major MEDLINE topics: Cholestasis. Cited 9 times so far (Crossref); 19 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Neonatal cholestasis is a group of disorders characterised by conjugated hyperbilirubinemia in the newborns and young infants. Advances in genetic testing have facilitated the identification of specific aetiology. This study examines the genetic and clinical profiles of neonates with cholestasis, focusing on genotype–phenotype correlations and diagnostic outcomes.

Methods

A retrospective review of children with neonatal cholestasis treated between 1997 and 2024 was conducted. Extrahepatic causes were excluded, and genetic testing, including a targeted cholestasis panel and whole exome sequencing (WES), was employed. Clinical and biochemical data, including gamma‐glutamyl transferase (GGT) levels, were collected.

Results

Genetic disorders were identified in 28.0% of 378 cases, including mutations in ATP8B1, ABCB11, ABCB4, DCDC2, DGUOK, KIF12, USP53, and genes related to bile acid synthesis (HSD3B7, PEX1). GGT levels played a significant role in diagnosis: patients with low or normal GGT were frequently diagnosed with progressive familial intrahepatic cholestasis (PFIC)1 and 2, or bile acid synthesis defects, while high GGT levels were associated with PFIC3, alpha‐1 antitrypsin deficiency, and cystic fibrosis. Consanguinity was noted in 56.0% of genetically diagnosed cases. After 2010, 35.5% of patients received a genetic diagnosis, compared to 18.2% before 2010.

Conclusion

Genetic diseases are a major cause of neonatal cholestasis, and GGT levels serve as a useful diagnostic tool in differentiating subtypes. The increasing availability of genetic testing has improved early diagnosis and personalised management. Expanded genetic testing in clinical practice is critical for timely and accurate diagnosis of these rare disorders.

Subjects

MeSH terms (MEDLINE)

CholestasisHumansInfant, NewbornRetrospective StudiesMaleFemalegamma-GlutamyltransferaseGenetic TestingMutationInfantGenetic Association Studies

Author keywords

gamma‐glutamyl transferasegenetic mutationsindirect bilirubinemianeonatal cholestasis

Substances

gamma-Glutamyltransferase

Authors and institutions

  • Department of Pediatric Gastroenterology, Ankara Training and Research Hospital, Ankara, Turkey.
  • Department of Pediatric Gastroenterology, Gazi University Faculty of Medicine, Ankara, Turkey.

ORCID profiles: Neslihan Gürcan Kaya, Hakan Öztürk, Sinan Sarı, Ödül Eğritaş Gürkan, Buket Dalgıç

Cite

APA

Gürcan Kaya, N., Öztürk, H., Sarı, S., Eğritaş Gürkan, Ö., & Dalgıç, B. (2025). Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70072

Vancouver

Gürcan Kaya N, Öztürk H, Sarı S, Eğritaş Gürkan Ö, Dalgıç B. Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.70072

BibTeX
@article{GrcanKaya2025,
  author = {Gürcan Kaya, Neslihan and Öztürk, Hakan and Sarı, Sinan and Eğritaş Gürkan, Ödül and Dalgıç, Buket},
  title = {Neonatal Cholestasis: Exploring Genetic Causes and Clinical Outcomes},
  journal = {Journal of Paediatrics and Child Health},
  year = {2025},
  doi = {10.1111/jpc.70072}
}
Start for free →